ConductScience.org, home

Paper35014759

Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.

O'Byrne LJ and 6 others. BJOG, 2022. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis. Papers, record 35014759. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35014759

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.
PubMed
Journal
BJOG
PubMed
Year
2022
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
2.93
iCite
Revised in PubMed
2025-06-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1O'Byrne LJLaura Jhttps://orcid.org/0000-0002-1916-2347
2Alqatari SGSafi G
3Maher GMGillian M
4O'Sullivan AMAoife M
5Khashan ASAli S
6Murphy GPGrainne P
7McCarthy FPFergus P

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
Premature BirthMajor topic
Cross-Sectional Studies
Female
Humans
Infant, Newborn
Pregnancy
Pregnancy Outcome
Prenatal Care

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
UCB pharmaPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in35015341Systematic reviews and meta-analyses: Bigger is not necessarily better.https://conductscience.org/library/papers/35015341

Source PubMed

Download CSV of comments and corrections

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116855148Epidemiological aspects of rheumatoid arthritis: the sex ratio.Ann N Y Acad Sci2006https://conductscience.org/library/papers/16855148PubMed
224284028Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study.Reprod Toxicol2014https://conductscience.org/library/papers/24284028PubMed
329961692Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy.J Rheumatol2018https://conductscience.org/library/papers/29961692PubMed
417185356A meta-analysis on the influence of inflammatory bowel disease on pregnancy.Gut2007https://conductscience.org/library/papers/17185356PubMed
525966992Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.Gut2016https://conductscience.org/library/papers/25966992PubMed
633046558Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life.Gut2021https://conductscience.org/library/papers/33046558PubMed
724980270Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.Aliment Pharmacol Ther2014https://conductscience.org/library/papers/24980270PubMed
833227283Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.Gastroenterology2021https://conductscience.org/library/papers/33227283PubMed
929771301Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type.J Crohns Colitis2018https://conductscience.org/library/papers/29771301PubMed
1030078176A Targeted Literature Review Examining Biologic Therapy Compliance and Persistence in Chronic Inflammatory Diseases to Identify the Associated Unmet Needs, Driving Factors, and Consequences.Adv Ther2018https://conductscience.org/library/papers/30078176PubMed
1129771477Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors: A Cohort Study.Arthritis Rheumatol2018https://conductscience.org/library/papers/29771477PubMed
1230231982Interferons and Proinflammatory Cytokines in Pregnancy and Fetal Development.Immunity2018https://conductscience.org/library/papers/30231982PubMed
1332118278
Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studies.
Rheumatology (Oxford)2020https://conductscience.org/library/papers/32118278PubMed
1419621072Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.PLoS Med2009https://conductscience.org/library/papers/19621072PubMed
1531692017Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.Aliment Pharmacol Ther2020https://conductscience.org/library/papers/31692017PubMed
1626873562Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan.Mod Rheumatol2016https://conductscience.org/library/papers/26873562PubMed
1728858070Anti-TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.Inflamm Bowel Dis2017https://conductscience.org/library/papers/28858070PubMed
1819577836Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses.Eur J Obstet Gynecol Reprod Biol2009https://conductscience.org/library/papers/19577836PubMed
1935014759Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.BJOG2022https://conductscience.org/library/papers/35014759PubMed
2029496718Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study.Ann Rheum Dis2018https://conductscience.org/library/papers/29496718PubMed

See all 51 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42766183Therapeutics Beyond Delivery: Repurposed Drugs and Biologic Pathways.Curr Hypertens Rep2026https://conductscience.org/library/papers/42766183PubMed
42650751Risk of Adverse Pregnancy Outcomes in Patients with Non-Communicable, Chronic Inflammatory Barrier Diseases Under Systemic Treatment: A Large-Scale Retrospective Cohort Study.Biomolecules2026https://conductscience.org/library/papers/42650751PubMed
42387357The Asia Pacific League of Associations for Rheumatology (APLAR) Consensus Statements for the Management of Reproductive Issues in Autoimmune Rheumatic Diseases.Int J Rheum Dis2026https://conductscience.org/library/papers/42387357PubMed
42271552Systemic lupus erythematosus and pregnancy: a comprehensive clinical review of maternal, fetal, and treatment considerations.Adv Rheumatol2026https://conductscience.org/library/papers/42271552PubMed
41822811The Role of Complement and CD4 T Cells in Preeclampsia and Offspring Neurodevelopment.Curr Opin Physiol2026https://conductscience.org/library/papers/41822811PubMed
41021022Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework.Rheumatol Int2025https://conductscience.org/library/papers/41021022PubMed
39812078Pharmacovigilance Pregnancy Data in a Population of Japanese Patients With Chronic Inflammatory Disease Exposed to Certolizumab Pegol.Int J Rheum Dis2025https://conductscience.org/library/papers/39812078PubMed
39699934Certolizumab pegol for plaque psoriasis in women of childbearing potential, pregnant or breastfeeding in clinical settings: One-year outcomes from the international noninterventional CIMREAL study.J Eur Acad Dermatol Venereol2025https://conductscience.org/library/papers/39699934PubMed
38690936TNF-α inhibitor use during pregnancy and the risk of preeclampsia: population-based cohort study.J Hypertens2024https://conductscience.org/library/papers/38690936PubMed
38202041Reproductive Safety Issues of Novel Small Molecules for the Treatment of Inflammatory Bowel Disease: A Systematic Review.J Clin Med2023https://conductscience.org/library/papers/38202041PubMed
37973775Effect of Anti-TNF Biologic Exposure During Pregnancy on Villitis of Unknown Etiology Diagnoses in Patients with Autoimmune Disease.Reprod Sci2024https://conductscience.org/library/papers/37973775PubMed
37272561Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases.J Korean Med Sci2023https://conductscience.org/library/papers/37272561PubMed
35693803Case Report: TNF-Alpha Inhibitors to Rescue Pregnancy in Women With Potential Pregnancy Loss: A Report of Ten Cases.Front Immunol2022https://conductscience.org/library/papers/35693803PubMed
35014759Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: A systematic review and meta-analysis.BJOG2022https://conductscience.org/library/papers/35014759PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL1A3552PubTator's text mininghttps://conductscience.org/library/genes/3552NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35014759

GET https://conductscience.org/api/papers/v1/35014759/references?page=2